J G Lewis Selected Research

Calcium Gluconate (CBG)

8/2016	Evidence of Reduced CBG Cleavage in Abdominal Obesity: A Potential Factor in Development of the Metabolic Syndrome.
6/2016	Corticosteroid-Binding Globulin: A Review of Basic and Clinical Advances.
1/2016	Evidence of Reduced CBG Cleavage in Abdominal Obesity: A Potential Factor in Development of the Metabolic Syndrome.
6/2015	Depletion of high-affinity corticosteroid-binding globulin corresponds to illness severity in sepsis and septic shock; clinical implications.
1/2012	CBG Santiago: a novel CBG mutation.
9/2010	Characteristics of plasma NOx levels in severe sepsis: high interindividual variability and correlation with illness severity, but lack of correlation with cortisol levels.
4/2010	Plasma sex hormone-binding globulin, corticosteroid-binding globulin, cortisol, and free cortisol levels in outpatients attending a lipid disorders clinic: a cross-sectional study of 1137 subjects.
3/2009	Plasma levels of sex hormone-binding globulin, corticosteroid-binding globulin and cortisol in overweight subjects who develop impaired fasting glucose: a 3-year prospective study.
9/2007	Moderate weight loss reduces renin and aldosterone but does not influence basal or stimulated pituitary-adrenal axis function.
4/2006	Plasma variation of corticosteroid-binding globulin and sex hormone-binding globulin.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J G Lewis Research Topics

Disease

6	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2016 - 07/2004
6	Insulin Resistance 11/2010 - 07/2004
3	Abdominal Obesity 08/2016 - 11/2010
3	Sepsis (Septicemia) 06/2015 - 01/2006
3	Septic Shock (Toxic Shock Syndrome) 06/2015 - 01/2006
2	Obesity 08/2016 - 07/2004
2	Inflammation (Inflammations) 06/2016 - 06/2015
2	Fatigue 06/2016 - 01/2012
2	Overweight 11/2009 - 03/2009
1	Body Weight (Weight, Body) 08/2016
1	Musculoskeletal Pain 06/2016
1	Chronic Pain 01/2012
1	Shock 09/2010
1	Weight Loss (Weight Reduction) 09/2007
1	Infections 01/2006
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2006
1	Convalescence 01/2006
1	Proteinuria 10/2002
1	Neoplasms (Cancer) 05/2000
1	Carcinogenesis 05/2000

Drug/Important Bio-Agent (IBA)

12	Calcium Gluconate (CBG)IBA 08/2016 - 07/2004
9	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2016 - 01/2006
6	TranscortinIBA 06/2015 - 07/2004
3	Sex Hormone-Binding GlobulinIBA 04/2010 - 07/2004
3	Glucose (Dextrose)FDA LinkGeneric 04/2010 - 03/2009
3	Insulin (Novolin)FDA Link 04/2010 - 03/2009
2	HDL CholesterolIBA 04/2010 - 11/2009
2	Triglycerides (Triacylglycerol)IBA 04/2010 - 11/2009
2	Biomarkers (Surrogate Marker)IBA 04/2006 - 07/2004
2	Carrier Proteins (Binding Protein)IBA 01/2006 - 07/2004
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2010
1	LipidsIBA 04/2010
1	HDL LipoproteinsIBA 11/2009
1	AdiponectinIBA 11/2009
1	1,1'- (4,4,7,7- tetramethyl- 4,7- diazaundecamethylene)bis- 4- (3- methyl- 2,3- dihydro(benzo- 1,3- thiazole)- 2- methylidene)quinolinium (TOTO)IBA 03/2009
1	AldosteroneIBA 09/2007
1	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2007
1	Cortisone FDA Link 09/2007
1	ReninIBA 09/2007
1	SaltsIBA 09/2007
1	AlbuminsIBA 01/2006
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2006
1	SteroidsIBA 07/2004
1	Antihypertensive Agents (Antihypertensives)IBA 10/2002
1	CarcinogensIBA 05/2000
1	CadmiumIBA 05/2000

Therapy/Procedure

1	Glycemic Control 11/2009